Clinical Trials Logo

Filter by:
NCT ID: NCT03245970 Withdrawn - Preeclampsia Clinical Trials

Impedance Cardiography to Decrease the Risk of Preeclampsia

Start date: April 24, 2017
Phase: Early Phase 1
Study type: Interventional

To determine if the use of impedance cardiography can identify appropriate medications for use in treating chronic hypertensive patients to decrease the risk of preeclampsia.

NCT ID: NCT03245671 Withdrawn - Clinical trials for Lumbar Spinal Stenosis

Particulate vs. Nonparticulate Epidural Steroid Injections for Lumbar Foraminal Stenosis

Start date: December 2017
Phase: Phase 4
Study type: Interventional

Chronic lumbosacral radiculopathy secondary to lumbar spinal stenosis affects a large number of individuals, and there is a general lack of consensus in the medical community in terms of effective treatments for this problem. By assessing the relative efficacy of transforaminal epidural injections of particulate and nonparticulate steroids, this study attempts to further define the appropriate conservative management of painful unilateral radiculopathies due to unilateral lumbar foraminal stenosis. Patients will be randomized to receive a transforaminal epidural injection of either a particulate (Kenalog) or nonparticulate (Decadron) steroid. Outcomes will be assessed at 2 weeks, 6 weeks, 3 months, and 6 months following the injection.

NCT ID: NCT03244852 Withdrawn - Clinical trials for Obsessive-Compulsive Disorder

Patient-specific, Effective, and Rational Functional Connectivity Targeting for DBS in OCD

PERFECT DBS
Start date: September 15, 2017
Phase:
Study type: Observational

The study aims to improve patient-specific anatomical targeting of the Deep Brain Stimulation for the treatment of intractable OCD.

NCT ID: NCT03243149 Withdrawn - PTSD Clinical Trials

Neurofeedback With Real-Time fMRI for Treatment of PTSD

Start date: July 1, 2022
Phase: N/A
Study type: Interventional

PTSD is a debilitating and costly condition and currently available treatment options have risks and limitations that necessitate development of novel interventions. Collectively, the functional brain imaging reports suggest that patients with PTSD, especially those with the re-experiencing and hypervigilence phenotype, show ventromedial PFC hypoactivation and amygdala hyperactivation in response to symptom provocation, and that treatment, when successful is associated with reduced amygdala and increased ventromedial PFC activation. This project is guided by a neurocircuit model of PTSD dysfunction in which abnormalities in fronto-limbic imbalance, which diminishes capacity for fear extinction learning, and produces PTSD symptoms of re-experiencing and hyperarousal. Thus, our studies aim to bridge the translational gap between theoretical and neurobiological models of PTSD to implementation of clinical practice. The Target Engagement and Dosing Phase of this project, which is a pilot study, will demonstrate target engagement and its association with laboratory measures of PTSD-relevant neural processes.

NCT ID: NCT03243058 Withdrawn - Diabetes Clinical Trials

Low-dose IL-2 in Established T1D - The "PROREG" Study

Start date: June 2023
Phase: Phase 1/Phase 2
Study type: Interventional

Randomized, controlled, double-blinded, multicenter, phase I/II clinical trial to evaluate the safety of low-dose IL-2 and determine whether low-dose IL-2 therapy for one year, can prevent further loss of beta-cell function in patients with established T1D, (primary outcome). The study will carefully examine various effects of low-dose IL-2 on the immune system in patients with T1D, including effects on Treg and other cell subsets, and disease-specific autoimmune responses.

NCT ID: NCT03243032 Withdrawn - Pain, Postoperative Clinical Trials

Pre-Emptive Analgesia in Dental Implant Surgery

Start date: October 6, 2017
Phase: Early Phase 1
Study type: Interventional

To determine the clinical effectiveness of combined use of pre-emptive analgesia and long acting anesthesia for pain suppression following dental implant surgery as measured by a validated numerical rating scale and the information related to consumption of post-operative medications.

NCT ID: NCT03242967 Withdrawn - Anemia Clinical Trials

Study to Evaluate Three Times Per Week (TIW) Oral Dosing of Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD)

TRILOGY
Start date: August 2017
Phase: Phase 3
Study type: Interventional

This is a Phase 3 Study to Evaluate Three Times Per Week (TIW) Oral Dosing of Vadadustat for Anemia in Subjects with Dialysis-Dependent Chronic Kidney Disease (DD-CKD)

NCT ID: NCT03242720 Withdrawn - Atrial Fibrillation Clinical Trials

Effects of PAP on Afib Recurrence Risk After Catheter Ablation in OSA Patients

OSA-AFIB
Start date: January 1, 2019
Phase: N/A
Study type: Interventional

With this pilot study, we are hoping to test the feasibility of a larger study in the future and to learn whether positive airway pressure therapy reduces the recurrence risk of atrial fibrillation after successful catheter ablation procedure among patients with atrial fibrillation and obstructive sleep apnea. The results from this study will help us refine the design for a future larger study, and will ultimately improve care of patients with obstructive sleep apnea and atrial fibrillation.

NCT ID: NCT03239197 Withdrawn - Microbiota Clinical Trials

Project SHARE (motherS Have All the Right microbEs)

Start date: September 5, 2017
Phase: N/A
Study type: Observational

This is an exploratory study designed to collect microbial samples from several body locations from 6 pairs of mothers and their newborn infants at various time points.

NCT ID: NCT03239054 Withdrawn - Pregnancy Clinical Trials

Prescribing Exercise as Medicine in Pregnancy

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

This study is a randomized controlled parallel arms trial. The purpose of this study is to evaluate if prescribing exercise in pregnancy can change maternal behavior towards exercise.